about
Characterization of an oxidoreductase from the arylamine N-acetyltransferase operon in Mycobacterium smegmatisUnderstanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model themCharacterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosisDNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay.Interaction of N-methyl-2-alkenyl-4-quinolones with ATP-dependent MurE ligase of Mycobacterium tuberculosis: antibacterial activity, molecular docking and inhibition kineticsProfiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis.Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case reportImproving the tuberculosis drug development pipeline.Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent AntituProTides of N-(3-(5-(2'-deoxyuridine))prop-2-ynyl)octanamide as potential anti-tubercular and anti-viral agents.A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus.Synthesis and biological evaluation of purpurealidin E-derived marine sponge metabolites: aplysamine-2, aplyzanzine A, and suberedamines A and B.Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase.Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatis.Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.Effective anti-tuberculosis therapy correlates with plasma small RNA.Antitubercular activity of Arctium lappa and Tussilago farfara extracts and constituents.Posterior stabilization of cervical spine injuries using the Roy-Camille plates: a long-term follow-up.Versatile routes to marine sponge metabolites through benzylidene rhodanines.Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: association with disease status.Gene analysis of the N-terminal region of the estrogen receptor alpha in preeclampsiaRapid methods for testing inhibitors of mycobacterial growthAntimycobacterials from lovage root (Ligusticum officinale Koch)Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpineComparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
P50
Q27674748-69B2F4F4-49AF-4840-927A-79FC6442A119Q28080526-7025D42B-50FF-4609-8A2B-8B5818FAB181Q28488668-2B0EE541-6E12-4CE5-B132-5771AE47B3DCQ30387972-8BD5AB77-7DD5-4924-9E79-FC4C9686F0B2Q34781823-9A613729-F134-42E2-8FF4-98A8FC2AD964Q35096913-791AB529-7D03-4FBC-A2C0-4CD9147D54C4Q35983023-7DEAEAD8-3CD7-4B3B-A333-DC9405FC0250Q36336273-D21F1477-E6C5-46BD-8840-5692EA848362Q36852681-8CE0AB07-E9CD-4D13-A96D-2322DF2C6915Q37667011-FF1FF814-95AF-4000-AD70-0A5B18D5AB78Q38378647-023ECA7D-3660-4FD5-9546-FB3E02185DD0Q38791576-4E6257C5-5752-4886-9BA5-CE8B5B84AE6EQ39009427-2F70F18B-6AE2-4BC4-9592-B0CE0EC2E427Q39080476-C558DAE8-FAE5-47D0-89B8-0D168C5082C3Q39343672-471CD951-D0DE-4164-AEEF-94EC7F5AECDDQ39417890-D7C1F32F-3744-4D7C-BF45-1C16DAB6FF12Q40174066-A76C1BFC-1DBA-49F0-AFEC-DAC2755A0F35Q41148810-816436F6-6CF6-4133-BA2C-8735D8B7FE8EQ42643574-7E43DD63-97A5-4CF5-B924-6084625DFDC1Q42933739-F6A83A62-8543-4BB8-A85A-69C9677CCA12Q45138225-6510313C-5CC5-423B-8BF3-8458B6B3D40DQ45173148-7B077D40-F3CE-485B-8660-4CA278E41E33Q48907701-88C5D5BF-5AFE-42FB-97D9-37559D5D6623Q51543288-8D984A76-C2E8-48F1-ABC6-31A50E1DF760Q54778824-B1C65265-F6B8-4EA7-9316-3671438D1E18Q74485238-91B39477-CDF0-41B1-B02A-CAAF35B9AC20Q84075182-A39F8A34-A748-467B-8A8F-EDFF979A9F54Q84815282-FFB5F69A-E824-4359-843A-AE6FCF661D35Q86563799-D9B8BDFB-9459-482A-8926-C8169420522DQ90100518-3B2E1270-B1ED-4018-A6B5-CA00BE3DBF48
P50
description
researcher ORCID ID = 0000-0003-0472-7576
@en
wetenschapper
@nl
name
Dimitrios Evangelopoulos
@ast
Dimitrios Evangelopoulos
@en
Dimitrios Evangelopoulos
@es
Dimitrios Evangelopoulos
@nl
type
label
Dimitrios Evangelopoulos
@ast
Dimitrios Evangelopoulos
@en
Dimitrios Evangelopoulos
@es
Dimitrios Evangelopoulos
@nl
prefLabel
Dimitrios Evangelopoulos
@ast
Dimitrios Evangelopoulos
@en
Dimitrios Evangelopoulos
@es
Dimitrios Evangelopoulos
@nl
P106
P1153
36880628000
P31
P496
0000-0003-0472-7576